Supplementary Figure S4 from Targeted Therapy to β3 Integrin Reduces Chemoresistance in Breast Cancer Bone Metastases

Gregory C. Fox(Washington University in St. Louis), Katherine N. Weilbaecher(Washington University in St. Louis), Kristin A. Kwakwa(Washington University in St. Louis), Sheila A. Stewart(Washington University in St. Louis), Yalin Xu(Washington University in St. Louis), Christopher A. Maher(Washington University in St. Louis), Vijay K. Sharma(Cornell University), Kristen Pagliai(Washington University in St. Louis), James A. J. Fitzpatrick(Washington University in St. Louis), Jothilingam Sivapackiam(Washington University in St. Louis), Elizabeth Cordell(Washington University in St. Louis), Alison K. Esser(Washington University in St. Louis), Michael H. Ross(Washington University in St. Louis), Suzanne J. Bakewell(Intezyne (United States)), Ha X. Dang(James S. McDonnell Foundation), Samuel Achilefu(Southwestern Medical Center), Xinming Su, Gregory M. Lanza(Washington University in St. Louis), Francesca Fontana, Jennifer L. Davis(Washington University in St. Louis), Deborah J. Veis(Washington University in St. Louis), Jingyu Xiang(Washington University in St. Louis)
Unknown
April 3, 2023
Cited by 0


Related Papers